Premorbid frailty predicts short- and long-term outcomes of reperfusion treatment in acute stroke.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 20 11 2021
accepted: 06 01 2022
revised: 03 01 2022
pubmed: 19 1 2022
medline: 24 5 2022
entrez: 18 1 2022
Statut: ppublish

Résumé

Frailty is the most important short- and long-term predictor of disability in the elderly and, thus, might influence the clinical outcome of acute treatment of stroke. To evaluate whether frailty predicts short- and long-term all-cause mortality and neurological recovery in elderly patients who underwent reperfusion acute treatment of stroke. The study included consecutive patients older than 65 years who underwent reperfusion treatment in a single stroke unit from 2015 to 2016. Predictors of stroke outcomes were assessed including demographics, baseline NIHSS, time to needle, treatment and medical complications. Premorbid frailty was assessed with a comprehensive geriatric assessment including functional, nutritional, cognitive, social and comorbidities status. At three and twelve months, all-cause death and clinical recovery (using modified Rankin scale, mRS) were evaluated. One-hundred and two patients who underwent acute reperfusion treatment for stroke entered the study (mean age 77.5, 65-94 years). Frailty was diagnosed in 32 out of 102 patients and associated with older age (p = 0.001) but no differences in baseline NIHSS score, vascular risk profile or treatment management strategy. Frailty status was associated with worse improvement at 24 h and higher in-hospital mortality. At follow-up, frail patients showed poorer survival at 3 (25% vs 3%, p = 0.008) and 12 (38% vs 7%, p = 0.001) months. Frailty was the best predictor of neurological recovery at one year follow-up (mRS 3.2 ± 1.9 vs 1.9 ± 1.9). Frailty is an important predictor of efficacy of acute treatment of stroke beyond classical predictors of stroke outcomes. Larger longitudinal studies are, thus, warranted to evaluate the risk-benefit of reperfusion treatment in the growing elderly frail population.

Sections du résumé

BACKGROUND BACKGROUND
Frailty is the most important short- and long-term predictor of disability in the elderly and, thus, might influence the clinical outcome of acute treatment of stroke.
OBJECTIVE OBJECTIVE
To evaluate whether frailty predicts short- and long-term all-cause mortality and neurological recovery in elderly patients who underwent reperfusion acute treatment of stroke.
METHODS METHODS
The study included consecutive patients older than 65 years who underwent reperfusion treatment in a single stroke unit from 2015 to 2016. Predictors of stroke outcomes were assessed including demographics, baseline NIHSS, time to needle, treatment and medical complications. Premorbid frailty was assessed with a comprehensive geriatric assessment including functional, nutritional, cognitive, social and comorbidities status. At three and twelve months, all-cause death and clinical recovery (using modified Rankin scale, mRS) were evaluated.
RESULTS RESULTS
One-hundred and two patients who underwent acute reperfusion treatment for stroke entered the study (mean age 77.5, 65-94 years). Frailty was diagnosed in 32 out of 102 patients and associated with older age (p = 0.001) but no differences in baseline NIHSS score, vascular risk profile or treatment management strategy. Frailty status was associated with worse improvement at 24 h and higher in-hospital mortality. At follow-up, frail patients showed poorer survival at 3 (25% vs 3%, p = 0.008) and 12 (38% vs 7%, p = 0.001) months. Frailty was the best predictor of neurological recovery at one year follow-up (mRS 3.2 ± 1.9 vs 1.9 ± 1.9).
DISCUSSION CONCLUSIONS
Frailty is an important predictor of efficacy of acute treatment of stroke beyond classical predictors of stroke outcomes. Larger longitudinal studies are, thus, warranted to evaluate the risk-benefit of reperfusion treatment in the growing elderly frail population.

Identifiants

pubmed: 35039903
doi: 10.1007/s00415-022-10966-7
pii: 10.1007/s00415-022-10966-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3338-3342

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Powers WJ, Rabinstein A, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update. Stroke 50(12):e344–e418
doi: 10.1161/STR.0000000000000211
Padovani A, Pilotto A (2020) Looking at the burden of neurological disorders in Europe. Lancet Public Health 5(10):523
doi: 10.1016/S2468-2667(20)30205-X
Appelros P, Nydevik I, Viitanen M (2003) Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke 34(1):122–126
doi: 10.1161/01.STR.0000047852.05842.3C
Winovich DT, Longstreth WTJ, Arnold AM, Varadhan R, Hazzouri AZA, Cushman M, Newman AB, Odden MC (2017) Factors associated with ischemic stroke survival and recovery in older adults. Stroke 48(7):1818–1826
doi: 10.1161/STROKEAHA.117.016726
Sharrief A, Grotta JC (2019) Stroke in the elderly. Handb Clin Neurol 167:393–418
doi: 10.1016/B978-0-12-804766-8.00021-2
Yourman LC, Sei JL, Schonberg MA, Widera EW, Smith AK (2012) Prognostic indices for older adults: a systematic review. JAMA 307(2):182–192
doi: 10.1001/jama.2011.1966
Evans NR, Wall J, To B, Wallis SJ, Romero-Ortuno R, Warburton EA (2020) Clinical frailty independently predicts early mortality after ischaemic stroke. Age Ageing 49(4):588–591
doi: 10.1093/ageing/afaa004
Wæhler IS, Saltvedt I, Lydersen S, Fure B, Askim T, Einstad MS, Thingstad P (2021) Association between in-hospital frailty and health-related quality of life after stroke: the Nor-COAST study. BMC Neurol 21(1):100
doi: 10.1186/s12883-021-02128-5
Kilkenny MF, Phan HT, Lindley RI, Kim J, Lopez D, Dalli LL, Grimley R, Sundararajan V, Thrift AG, Andrew NE, Donnan GA, Cadilhac DA, Stroke123 Investigators and the AuSCR Consortium (2021) Utility of the hospital frailty risk score derived from administrative data and the association with stroke outcomes. Stroke 52(9):2874–2881
doi: 10.1161/STROKEAHA.120.033648
Sancarlo D, Pilotto A, Panza F, Copetti M, Longo MG, D’ambrosio P, D’Onofrio G, Ferrucci L, Pilotto A (2012) A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack. J Neurol 259(4):670–678
doi: 10.1007/s00415-011-6241-4
Pinho J, Kueppers C, Nikoubashman O, Wiesman M, Schulz JB, Reich A, Werner CJ (2021) Frailty is an outcome predictor in patients with acute ischemic stroke receiving endovascular treatment. Age Ageing 50(5):1785–1791
doi: 10.1093/ageing/afab092
Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J (1994) Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group Stroke 25(11):2220–2226
Pilotto A, Ferrucci L, Franceschi M, D’Ambrosio LP, Scarcelli C, Cascavilla L, Paris F, Placentino G, Seripa D, Dallapiccola B, Leandro G (2008) Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rej Res 11(1):151–161
doi: 10.1089/rej.2007.0569
Kugler C, Altenhöner T, Lochner P, Ferbert A (2003) Does age influence early recovery from ischemic stroke? A study from the Hessian Stroke Data Bank. J Neurol 250(6):676–681
doi: 10.1007/s00415-003-1054-8
Chen CJ, Ding D, Starke RM, Mehndiratta P, Crowley RW, Liu KC, Southerland AM, Worrall BB (2015) Endovascular vs medical management of acute ischemic stroke. Neurology 85(22):1980–1990
doi: 10.1212/WNL.0000000000002176
Kanai M, Noguchi M, Kubo H, Nozoe M, Kitano T, Izawa KP, Mase K, Shimada S (2020) Pre-stroke frailty and stroke severity in elderly patients with acute stroke. J Stroke Cerebrovasc Dis 29(12):105346
doi: 10.1016/j.jstrokecerebrovasdis.2020.105346
Ohba H, Ohbayashi N, Fukuda H, Yahara K, Nabika S, Suto Y, Tokuda N, Yoshida K, Nakaoka M, Sakamoto S (2021) Predictors of reperfusion and 90-day functional outcome after mechanical thrombectomy for large vessel occlusion strokes. J Stroke Cerebrovasc Dis 30(5):105687
doi: 10.1016/j.jstrokecerebrovasdis.2021.105687
Fujita K, Tanaka K, Yamagami H, Yoshimoto T, Uchida K, Morimoto T, Imamura H, Sakai N, Ohara N, Matsumoto Y et al (2021) Outcomes of large vessel occlusion stroke in patients aged ≥ 90 years. Stroke 52(5):1561–1569
doi: 10.1161/STROKEAHA.120.031386
Bu N, Khlif MS, Lemmens R, Wouters A, Fiebach JB, Chamorro A, Ringelstein EB, Norrving B, Laage R, Grond M et al (2021) Imaging markers of brain frailty and outcome in patients with acute ischemic. Stroke 52:1004–1011
doi: 10.1161/STROKEAHA.120.029841

Auteurs

Andrea Pilotto (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.zale Spedali Civili, 1-25213, Brescia, Italy. pilottoandreae@gmail.com.
FERB Onlus, Ospedale S. Isidoro, Trescore Balneario, Bergamo, Italy. pilottoandreae@gmail.com.

Cora Brass (C)

Department of Neurology, Kreisklinikum Siegen, Siegen, Germany.

Klaus Fassbender (K)

Department of Neurology, University of the Saarland, Homburg, Saar, Germany.

Fatma Merzou (F)

Department of Neurology, University of the Saarland, Homburg, Saar, Germany.

Andrea Morotti (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.zale Spedali Civili, 1-25213, Brescia, Italy.

Niklas Kämpfer (N)

Department of Neurology, University of the Saarland, Homburg, Saar, Germany.

Antonio Siniscalchi (A)

Department of Neurology and Stroke Unit, Annunziata Hospital of Cosenza, Cosenza, Italy.

Alessandro Padovani (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.zale Spedali Civili, 1-25213, Brescia, Italy.

Piergiorgio Lochner (P)

Department of Neurology, University of the Saarland, Homburg, Saar, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH